Direct Inhibition of Ih by Analgesic Loperamide in Rat DRG Neurons

1 Discovery Neuroscience and 2 Chemical and Screening Sciences, Wyeth Research, Princeton, New Jersey Submitted 10 August 2006; accepted in final form 18 March 2007 Hyperpolarization-activated cyclic nucleotide–gated (HCN) channels are responsible for the functional hyperpolarization-activated curre...

Full description

Saved in:
Bibliographic Details
Published inJournal of neurophysiology Vol. 97; no. 5; p. 3713
Main Authors Vasilyev, Dmitry V, Shan, Qin, Lee, Yan, Mayer, Scott C, Bowlby, Mark R, Strassle, Brian W, Kaftan, Edward J, Rogers, Kathryn E, Dunlop, John
Format Journal Article
LanguageEnglish
Published United States Am Phys Soc 01.05.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:1 Discovery Neuroscience and 2 Chemical and Screening Sciences, Wyeth Research, Princeton, New Jersey Submitted 10 August 2006; accepted in final form 18 March 2007 Hyperpolarization-activated cyclic nucleotide–gated (HCN) channels are responsible for the functional hyperpolarization-activated current ( I h ) in dorsal root ganglion (DRG) neurons, playing an important role in pain processing. We found that the known analgesic loperamide inhibited I h channels in rat DRG neurons. Loperamide blocked I h in a concentration-dependent manner, with an IC 50 = 4.9 ± 0.6 and 11.0 ± 0.5 µM for large- and small-diameter neurons, respectively. Loperamide-induced I h inhibition was unrelated to the activation of opioid receptors and was reversible, voltage-dependent, use-independent, and was associated with a negative shift of V 1/2 for I h steady-state activation. Loperamide block of I h was voltage-dependent, gradually decreasing at more hyperpolarized membrane voltages from 89% at –60 mV to 4% at –120 mV in the presence of 3.7 µM loperamide. The voltage sensitivity of block can be explained by a loperamide-induced shift in the steady-state activation of I h . Inclusion of 10 µM loperamide into the recording pipette did not affect I h voltage for half-maximal activation, activation kinetics, and the peak current amplitude, whereas concurrent application of equimolar external loperamide produced a rapid, reversible I h inhibition. The observed loperamide-induced I h inhibition was not caused by the activation of peripheral opioid receptors because the broad-spectrum opioid receptor antagonist naloxone did not reverse I h inhibition. Therefore we suggest that loperamide inhibits I h by direct binding to the extracellular region of the channel. Because I h channels are involved in pain processing, loperamide-induced inhibition of I h channels could provide an additional molecular mechanism for its analgesic action. Address for reprint requests and other correspondence: D. Vasilyev, Discovery Neuroscience, Wyeth Research, CN 8000, Princeton, NJ 08543-8000 (E-mail: vasylyd{at}wyeth.com )
ISSN:0022-3077
1522-1598
DOI:10.1152/jn.00841.2006